• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: B. BRAUN MEDICAL INC. INFUSOMAT®; SET, ADMINISTRATION, INTRA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

B. BRAUN MEDICAL INC. INFUSOMAT®; SET, ADMINISTRATION, INTRA Back to Search Results
Model Number 490100
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Low Blood Pressure/ Hypotension (1914)
Event Date 06/16/2023
Event Type  Injury  
Manufacturer Narrative
This report has been identified as b.Braun medical internal report number (b)(4).The investigation is ongoing at this time.A follow up will be submitted when the investigation results become available.Please note that this report is for the pump set in which there is no indication of a malfunction at this time.
 
Event Description
As reported by the user facility: description of the patient event could not infuse critical drip of norepi the clinician kept receiving downstream occlusion alarms that they could not resolve.Patient injury or death yes - death.These are the additional details b.Braun obtained with the account after a meeting on 22.June.2023: infusion started on (b)(6).No occlusion alarms, until 1:22 a.M.Of (b)(6); pressure alarm at 3:09 a.M., then 4:56 a.M.The infusion was infusing through a triple lumen catheter in the neck.Other drugs were running, but not on the same lumen (they do not piggyback or double-up vasopressors).There were four (4) or five (5) other pumps connected to the patient.The drugs the patient was receiving were norepinephrine, fentanyl, dextrose, levophed, vasopressin, and bicarb.The patient was very sick and they were talking about the potential to put in place comfort measures for end of life when the incident occurred.The patient's blood pressure had not been great all day prior to the event.All lines other than the norepinephrine were running without issue except the fentanyl had to be increased once.It was reported that at one point the patient seemed to go "rigid" and had some "stiffening".That may have lead them to increase the doserate of fentanyl from 50 - 75, but it is unclear whether that was the reason for the increase in rate.There were no identified kinks or blockages in the norepinephrine line and they had good blood return.They even tried to adjust the patient in case there was some occlusion in the anatomy, but this did not have an impact on the occlusion alarms.Cather placements: patient had a triple lumen and a mid-line in the right upper arm and a peripheral iv in the left arm.Only one lumen of the triple-lumen was being used for the patient.Customer was only able to get dosetrac info for the morning of (b)(6).Likely because the wireless signal in the area may not be good.Possible lot numbers: lot 0061875889; expiry date 01/31/2026; production date 02/13/2023.Lot 0061880238; expiry date 02/28/2026; production date 03/22/2023.
 
Manufacturer Narrative
This report has been identified as b.Braun medical internal report number (b)(4).Please note that originally when the report was received, it was unclear if the death mentioned was related.However, a call was held between b.Braun and the clinical nurse specialist medication safety for (b)(6) on 22.Jun.2023.During the call on 22jun2023, the clinician identified that the cause of death was believed to be sepsis but provided contact information to the risk management department for further details.Multiple attempts (2 emails on 23jun2023 & 29jun2023, one phone call on 07jul2023, and a site visit on 12jul2023) were made to discuss and obtain additional details regarding the patient outcome.At this time, no additional information has been provided by the customer.As such, this report is submitted amending section b2, h1, and h6 to reflect serious injury.Representative from b.Braun went to the hospital to retrieve the set used within the incident and sent with pump to affiliate site for testing; however, unfortunately, the actual device was inadvertently discarded during decontamination and not available for further testing at the manufacturing site.We will maintain this report for further references and continue to monitor other reports for similar occurrences.If any additional pertinent information becomes available, a follow up will be submitted.
 
Event Description
Please note that during the call on 22.Jun.2023 between b.Braun and the clinical nurse specialist medication safety for (b)(6) the clinician identified that the cause of death was believed to be sepsis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INFUSOMAT®
Type of Device
SET, ADMINISTRATION, INTRA
Manufacturer (Section D)
B. BRAUN MEDICAL INC.
901 marcon blvd.
allentown PA 18109
Manufacturer (Section G)
B. BRAUN DOMINICIAN REPULIC INC.
las americas industrial park
km22 autopista las americas
santo domingo,
DR  
Manufacturer Contact
jonathan severino
901 marcon blvd.
allentown, PA 18109
4847197287
MDR Report Key17299519
MDR Text Key318787917
Report Number2523676-2023-00323
Device Sequence Number1
Product Code FPA
UDI-Device Identifier04046964186080
UDI-Public(01)04046964186080
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K142036
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 09/18/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number490100
Device Catalogue Number490100
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/20/2023
Initial Date FDA Received07/11/2023
Supplement Dates Manufacturer Received06/20/2023
Supplement Dates FDA Received09/18/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Required Intervention;
-
-